|
Press Release |
15 October 2010 |
LiDCO Group Plc
("LiDCO" or the "Company")
LiDCO Group plc (AIM: LID), the cardiovascular monitoring company, is pleased to announce that GE Healthcare ("GE"), a unit of General Electric Company (NYSE: GE) and a leading provider of information technology solutions, has successfully completed development of a proprietary communications link between LiDCO monitors and GE's Centricity Clinical Information Systems available in Europe, the Middle East and Africa. The link will allow GE's EMEA customers to access data from LiDCO's proprietary, minimally-invasive hemodynamic monitor via GE's Centricity Critical Care and Centricity Anesthesia systems. The new link for the EMEA market complements the GE Centricity Enterprise system in the US which already has a communications link to LiDCO via Capsule Tech.
The integration of critical care parameters with data derived from the LiDCOrapid and LiDCOplus monitors, will allow a fuller picture of a patient's condition and history to be displayed and accessed from GE's interfaces throughout a hospital.
Connecting LiDCO's monitors with key medical technology infrastructure will improve hospital workflows and productivity, providing a second interface from which physicians can access patient data. The technology will be attractive to hospitals looking to streamline operations and improve efficiencies across technology platforms. The link has been available from Q3 2010 for LiDCOrapid V1.03 and LIDCOplus V4.01s.
Dr. Terry O'Brien, Chief Executive Officer of LiDCO, commented: "With technology use rising in hospitals, it becomes increasingly important for different systems and equipment to communicate with each other in order to help make informed decisions about patient care. The communication link for LiDCO's monitors and GE Centricity will give users another platform from which to access and analyse data, enhancing the utility of LiDCO's monitoring platforms for both our existing and GE's future customers."
- ENDS -
For more information please contact:
|
LiDCO Group Plc |
|
|
Terry O'Brien - Chief Executive John Rowland - Company Secretary |
Tel: +44 (0)20 7749 1500 |
|
FinnCap |
|
|
Geoff Nash / Stephen Norcross / Henrik Persson |
+44 (0)20 7600 1658 |
Media enquiries
|
Abchurch Communications |
|
|
Heather Salmond / Joanne Shears / Simone Elviss |
+44 (0)20 7398 7728 |
|
|
About LiDCO Group Plc
LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the measurement, analysis, audit, training and sharing of real-time and historic hemodynamic data, in both critical care units and the operating theatre.
Scientific evidence is increasingly linking the optimisation of patients' hemodynamic status with better outcomes and reduced hospital stays and LiDCO's computer-based technology, developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay & overall costs associated with major surgery.
Key Products:
|
LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%) |
|
|
LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anesthetists to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapid provides: |
|
|
· |
early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug |
|
· |
quantification of hemodynamic response, |
|
· |
guidance on effective delivery of fluids to ensure the right amount at the right time |
|
LiDCOview: an easy-to-use graphical display of historical LiDCOplus and LiDCOrapid hemodynamic data. |
|
All LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream. LiDCO, in collaboration with Covidien (Nasdaq: IDYN), is currently developing a simultaneous brain and hemodynamic monitoring platform to provide clinicians with the market's most evolved fluid and hemodynamic monitoring product for high-risk surgery patients.
Clinical Validation & Education
LiDCO has been selected as the sole technology for two ongoing multi-centre government-funded studies in the UK and US. OPTIMISE is sponsored by the UK Government for optimising cardiovascular management in high-risk abdominal surgery patients and in the US, MOnIToR is a US Government sponsored transplantation donor organ optimisation study. The Company has also developed a hemodynamic workshop at St George's Hospital, London.
LiDCO Distribution Network:
LiDCO products are sold through Covidien's sales force in the US. LiDCO's strategy is to sell directly to hospitals in the UK, and through a network of specialty critical care and anesthesia distributors in the rest of the world.
LiDCO's sales office is in Cambridge, its manufacturing facility and headquarters are in London and its shares are traded on AIM. For more information please see www.lidco.com.
About GE Centricity Clinical Information Systems
GE Centricity Clinical Informations Systems is an integrated suite of IT solutions for Intensive Care, Anesthesia and OR Management. They deliver information at the centre of care, when needed and where needed, to help organizations achieve more effective and efficient decisions.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Its broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help its customers to deliver better care to more people around the world at a lower cost. In addition, it partners with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. GE Healthcare's "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit www.gehealthcare.com.